Home › Sakit ni Alzheimer › Michigan
Pag-aaral pangklinika para sa Sakit ni Alzheimer sa Michigan
15 pag-aaral para sa Sakit ni Alzheimer ang naghahanap ng mga kalahok sa mga site sa Michigan.
Mga Lungsod sa Michigan
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1620, Troy
Nagre-recruitPhase 3
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 4
Edad 50 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07633470A Study of LY3439539 in Participants With Alzheimer's Disease
- QUEST Research Institute, Farmington Hills
Nagre-recruitPhase 1
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07598370A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Neurobehavioral Medicine Group (NBMG), Bloomfield Township
Nagre-recruitPhase 3
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06585787A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- QUEST Research Institute, Farmington Hills
Nagre-recruitPhase 2
Edad 55 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589595Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 3
Edad 50 hanggang 90 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- QUEST Research Institute, Farmington Hills
Nagre-recruitPhase 3
Edad 60 hanggang 85 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- NeuroBehavioral Medicine Group, Bloomfield Hills
- Oakland Medical Research, Troy
Nagre-recruitPhase 3
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07011732Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Michigan Medicine, Ann Arbor
Nagre-recruit
Edad 70 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05929703Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0088, Sterling Heights
Nagre-recruitPhase 2
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06808984Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06563895Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
- Shiawasee Health Department, Corunna
- McLaren Flint OB-GYN, Flint
- Munson Gaylord OB-GYN, Gaylord
- at 5 pa
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Hul 24, 2026 · NCT07213284A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Revival Research Institute, LLC, Southfield
Nagre-recruitPhase 3
Edad 55 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- QUEST Research Institute, Farmington Hills
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 85 · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06657768Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Quest Research Institute, Farmington Hills
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 60 hanggang 90 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT06584357Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.